These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 4822649)

  • 1. Exploratory laparotomy in recurrent cervical cancer.
    Hardman AA; Daly JW
    Obstet Gynecol; 1974 May; 43(5):653-7. PubMed ID: 4822649
    [No Abstract]   [Full Text] [Related]  

  • 2. Exploratory laparotomy as routine pretreatment investigation in cancer of the cervix.
    Ucmakli A; Bonney WA
    Radiology; 1972 Aug; 104(2):371-7. PubMed ID: 5044993
    [No Abstract]   [Full Text] [Related]  

  • 3. Anterior pelvic exenteration.
    Hatch KD; Shingleton HM; Soong SJ; Baker VV; Gelder MS
    Gynecol Oncol; 1988 Sep; 31(1):205-16. PubMed ID: 3410348
    [No Abstract]   [Full Text] [Related]  

  • 4. Cancer of the cervical stump. Study of 173 patients.
    Wolff JP; Lacour J; Chassagne D; Berend M
    Obstet Gynecol; 1972 Jan; 39(1):10-6. PubMed ID: 5008268
    [No Abstract]   [Full Text] [Related]  

  • 5. Pelvic exenteration for adenocarcinoma of the uterine cervix.
    Crozier M; Morris M; Levenback C; Lucas KR; Atkinson EN; Wharton JT
    Gynecol Oncol; 1995 Jul; 58(1):74-8. PubMed ID: 7789894
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors for curative pelvic exenterations in patients with recurrent uterine cervical or vaginal cancer.
    Sardain H; Lavoué V; Laviolle B; Henno S; Foucher F; Levêque J
    Int J Gynecol Cancer; 2014 Nov; 24(9):1679-85. PubMed ID: 25254565
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.
    Terán-Porcayo MA; Zeichner-Gancz I; del-Castillo RA; Beltrán-Ortega A; Solorza-Luna G
    Med Oncol; 2006; 23(2):219-23. PubMed ID: 16720922
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative radiotherapy for uterine cervical cancer: impact of lymph node and histological type on survival.
    Kasuya G; Ogawa K; Iraha S; Nagai Y; Hirakawa M; Toita T; Kakinohana Y; Kudaka W; Inamine M; Ariga T; Aoki Y; Murayama S
    Anticancer Res; 2013 May; 33(5):2199-204. PubMed ID: 23645776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radical hysterectomy and pelvic lymphadenectomy for carcinoma of the uterine cervix.
    Ketcham AS; Hoye RC; Taylor PT; Deckers PJ; Thomas LB; Chretien PB
    Cancer; 1971 Nov; 28(5):1272-7. PubMed ID: 5125675
    [No Abstract]   [Full Text] [Related]  

  • 10. Critical points of failure in the therapy of cancer of the cervix: a reappraisal.
    Halpin TF; Frick HC; Munnell EW
    Am J Obstet Gynecol; 1972 Nov; 114(6):755-64. PubMed ID: 4633572
    [No Abstract]   [Full Text] [Related]  

  • 11. [Interstitial radiotherapy in combined treatment of cervix cancer].
    Nechushkin MI; Mar'ina LA; Zinov'ev NE; Strakhov VIu; Sakharova OV
    Vopr Onkol; 1998; 44(5):518-21. PubMed ID: 9884706
    [No Abstract]   [Full Text] [Related]  

  • 12. A clinical-pathological correlation of cell type classification for cervical cancer.
    Swan DS; Roddick JW
    Am J Obstet Gynecol; 1973 Jul; 116(5):666-70. PubMed ID: 4713130
    [No Abstract]   [Full Text] [Related]  

  • 13. Prognostic significance of cervical lesion size and pelvic node metastases in cervical carcinoma.
    Piver MS; Chung WS
    Obstet Gynecol; 1975 Nov; 46(5):507-10. PubMed ID: 1196552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Course and prognosis of the disease in relation to the clinical and histopathological forms of cervical cancer].
    Peteja J; Rzempołuch J; Mecik I; Cofała Z; Korzeń Z
    Ginekol Pol; 1986 Apr; 57(4):309-14. PubMed ID: 3758770
    [No Abstract]   [Full Text] [Related]  

  • 15. Carcinoma of the cervix. II. A critical evaluation of patient follow-up.
    Van Voorhis LW
    Am J Obstet Gynecol; 1970 Sep; 108(1):115-21. PubMed ID: 5454576
    [No Abstract]   [Full Text] [Related]  

  • 16. A comparison of pure adenocarcinoma and squamous cell carcinoma of the cervix after radical hysterectomy in stage IB-IIA.
    Lee YY; Choi CH; Kim TJ; Lee JW; Kim BG; Lee JH; Bae DS
    Gynecol Oncol; 2011 Mar; 120(3):439-43. PubMed ID: 21145099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Does adenocarcinoma of uterine cervix have a worse prognosis than squamous carcinoma?].
    Recoules-Arche A; Rouzier R; Rey A; Villefranque V; Haie-Meder C; Pautier P; Pomel C; Lhommé C; Duvillard P; Castaigne D; Morice P
    Gynecol Obstet Fertil; 2004 Feb; 32(2):116-21. PubMed ID: 15123133
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of stage I carcinoma of the cervix.
    Park RC; Patow WE; Rogers RE; Zimmerman EA
    Obstet Gynecol; 1973 Jan; 41(1):117-22. PubMed ID: 4682607
    [No Abstract]   [Full Text] [Related]  

  • 19. Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.
    Hille A; Weiss E; Hess CF
    Strahlenther Onkol; 2003 Nov; 179(11):742-7. PubMed ID: 14605743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. How valid are current cervical cancer prognostic factors that are used to recommend adjunctive radiation therapy after radical surgery?
    Creasman WT; Kohler M; Korte JE
    Am J Obstet Gynecol; 2009 Sep; 201(3):260.e1-3. PubMed ID: 19539891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.